BARCLAYS PLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$2,283
-23.8%
142,372
+10.1%
0.00%
-50.0%
Q2 2023$2,997
+23.5%
129,304
+23.7%
0.00%
+100.0%
Q1 2023$2,427
+18.2%
104,510
-26.1%
0.00%0.0%
Q4 2022$2,053
-99.9%
141,447
+5.4%
0.00%
-66.7%
Q3 2022$2,561,000
+315.1%
134,244
+295.4%
0.00%
Q2 2022$617,000
-65.5%
33,953
-52.2%
0.00%
-100.0%
Q1 2022$1,790,000
-71.5%
71,015
-68.8%
0.00%0.0%
Q4 2021$6,278,000
+89.8%
227,426
+122.0%
0.00%0.0%
Q3 2021$3,308,000
+134.9%
102,424
+122.4%
0.00%0.0%
Q2 2021$1,408,000
-50.5%
46,048
-50.7%
0.00%
-50.0%
Q1 2021$2,846,000
+67.0%
93,485
+8.5%
0.00%
+100.0%
Q4 2020$1,704,000
-15.5%
86,190
-44.2%
0.00%0.0%
Q3 2020$2,016,000
+149.8%
154,591
+117.3%
0.00%0.0%
Q2 2020$807,000
-73.1%
71,149
-66.0%
0.00%
-50.0%
Q1 2020$2,996,000
-74.0%
209,297
-50.6%
0.00%
-66.7%
Q4 2019$11,531,000
+299.7%
423,447
+320.1%
0.01%
+500.0%
Q3 2019$2,885,000
-67.1%
100,794
-68.1%
0.00%
-80.0%
Q2 2019$8,774,000
+85.3%
315,855
+121.4%
0.01%
+66.7%
Q1 2019$4,735,000
+379.3%
142,646
+319.6%
0.00%
+200.0%
Q4 2018$988,000
-78.9%
33,993
-66.6%
0.00%
-66.7%
Q3 2018$4,684,000
+153.5%
101,841
+105.8%
0.00%
+200.0%
Q2 2018$1,848,000
-62.9%
49,481
-70.7%
0.00%
-75.0%
Q1 2018$4,983,000
+116.7%
168,608
+151.9%
0.00%
+100.0%
Q4 2017$2,299,000
-40.4%
66,940
-37.2%
0.00%
-33.3%
Q3 2017$3,858,000
+10.4%
106,607
-21.1%
0.00%0.0%
Q2 2017$3,494,000
+68.2%
135,183
+25.0%
0.00%
+50.0%
Q1 2017$2,077,000
-7.7%
108,179
-19.8%
0.00%0.0%
Q4 2016$2,250,000
-8.9%
134,957
+12.4%
0.00%0.0%
Q3 2016$2,471,000
+319.5%
120,084
+524.7%
0.00%
+100.0%
Q2 2016$589,000
-52.0%
19,223
-42.0%
0.00%0.0%
Q1 2016$1,227,000
-19.5%
33,152
-6.4%
0.00%
-50.0%
Q4 2015$1,524,000
-82.0%
35,417
-84.5%
0.00%
-80.0%
Q3 2015$8,447,000
+62.4%
228,262
+44.8%
0.01%
+66.7%
Q2 2015$5,201,000
-51.9%
157,610
-49.0%
0.01%
-50.0%
Q1 2015$10,815,000
+84.8%
309,021
+79.5%
0.01%
+100.0%
Q4 2014$5,852,000
-19.8%
172,120
-10.4%
0.01%
-14.3%
Q3 2014$7,300,000
-16.0%
192,079
-16.0%
0.01%
-22.2%
Q2 2014$8,693,000
-18.2%
228,776
-26.8%
0.01%
-25.0%
Q1 2014$10,625,000
-32.1%
312,466
-60.0%
0.01%
-25.0%
Q4 2013$15,643,000
+74.5%
782,119
+100.6%
0.02%
+60.0%
Q3 2013$8,966,000
-39.7%
389,831
-29.6%
0.01%
-47.4%
Q2 2013$14,874,000553,5480.02%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders